Form F-6 POS Biofrontera AG/ADR Filed by: BANK OF NEW YORK / ADR DIVISION streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Biofrontera , an international biopharmaceutical company, announces that the U.S. Food and Drug Administration has added the patent of novel RhodoLED® XL lamp to the FDA Orange Book and further. | March 14, 2022
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Biofrontera AG announces the closing of the capital raise with gross proceeds of EUR 24.7 million
Biofrontera AGFebruary 26, 2021 GMT
Leverkusen, Germany, Feb. 26, 2021 (GLOBE NEWSWIRE) Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (“Biofrontera” or the “Company”), an international biopharmaceutical company, announces the closing of the capital increase resolved by the annual general meeting on May 28, 2020.
The capital increase was carried out by way of a subscription rights offering to existing shareholders of Biofrontera AG under German law. Unsubscribed shares were placed in the course of a public offering of American Depositary Shares (“ADS” and “ADS Offering”) in the United States. The Company raised total gross proceeds of approximately EUR 24.7 million.
Business news for the stock market
Biofrontera AG: Biofrontera AG announces the closing of the capital raise with gross proceeds of EUR 24.7 million
Leverkusen (pta046/26.02.2021/15:20) - Leverkusen, Germany, February 26, 2021- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) ( Biofrontera or the Company ), an international biopharmaceutical company, announces the closing of the capital increase resolved by the annual general meeting on May 28, 2020.
The capital increase was carried out by way of a subscription rights offering to existing shareholders of Biofrontera AG under German law. Unsubscribed shares were placed in the course of a public offering of American Depositary Shares ( ADS and ADS Offering ) in the United States. The Company raised total gross proceeds of approximately EUR 24.7 million.